Discontinuation of Immunosuppressive Therapy in Patients With Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies

OBJECTIVE: To evaluate the outcomes of immunosuppressive therapy (IST) discontinuation in patients with neuromyelitis optica spectrum disorder (NMOSD) after a sustained remission period. METHODS: We retrospectively reviewed the medical records of 17 patients with antiaquaporin-4 antibody-positive NM...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neurol Neuroimmunol Neuroinflamm
Main Authors: Kim, Su-Hyun, Jang, Hyunmin, Park, Na Young, Kim, Yeseul, Kim, So-Yeon, Lee, Min Young, Hyun, Jae-Won, Kim, Ho Jin
Formato: Artigo
Idioma:Inglês
Publicado: Lippincott Williams & Wilkins 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7903808/
https://ncbi.nlm.nih.gov/pubmed/33622675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000947
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares